KG
WST icon

Kilter Group’s West Pharmaceutical WST Stock Holding History

Kilter Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.31K Hold
12
– – ﹤0.01% 721
2026
Q1 		$3.01K Sell
12
-5
-29% -$1.24K ﹤0.01% 786
2025
Q4 		$4.68K Buy
17
+3
+21% +$821 ﹤0.01% 522
2025
Q3 		$3.67K Sell
14
-11
-44% -$2.67K ﹤0.01% 517
2025
Q2 		$5.47K Buy
+25
New +$5.34K ﹤0.01% 384

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Kilter Group's WST Position: Q2 2026 in Review

Kilter Group held its West Pharmaceutical (WST) position steady in Q2 2026 at 12 shares worth $4.31K. The position accounts for ﹤0.01% of the portfolio, ranked #721.

Kilter Group first reported a position in WST in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.47K in Q2 2025. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Kilter Group held 12 shares of West Pharmaceutical worth $4.31K as of Q2 2026.
  • Kilter Group left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #721 holding.
  • Kilter Group first reported a position in West Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • Kilter Group's West Pharmaceutical position peaked at $5.47K in Q2 2025.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.